New hope for hearts damaged by cancer treatment
NCT ID NCT05194111
Summary
This study is testing if a heart medication called sacubitril/valsartan is safe and practical for young adult cancer survivors who have early signs of heart damage from their past cancer therapy. The goal is to see if the drug can be used to help control this heart condition before symptoms develop. Researchers will enroll about 53 survivors who had cancer before age 40 and have specific signs of early heart dysfunction but no current symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.